×
S&P 500   4,148.93 (+2.24%)
DOW   33,137.72 (+1.53%)
QQQ   308.13 (+2.94%)
AAPL   149.10 (+3.70%)
MSFT   271.66 (+2.17%)
FB   194.76 (+1.63%)
GOOGL   2,240.71 (+3.94%)
AMZN   2,282.03 (+2.72%)
TSLA   757.43 (+7.02%)
NVDA   188.12 (+5.38%)
BABA   93.23 (-1.32%)
NIO   16.47 (+2.74%)
AMD   102.11 (+3.40%)
CGC   4.85 (-12.61%)
MU   73.30 (+3.82%)
T   21.25 (-0.33%)
GE   78.40 (+1.80%)
F   13.57 (+3.43%)
DIS   109.32 (+3.51%)
AMC   14.39 (+17.66%)
PFE   53.66 (-0.61%)
PYPL   85.13 (+5.86%)
NFLX   194.45 (+1.59%)
S&P 500   4,148.93 (+2.24%)
DOW   33,137.72 (+1.53%)
QQQ   308.13 (+2.94%)
AAPL   149.10 (+3.70%)
MSFT   271.66 (+2.17%)
FB   194.76 (+1.63%)
GOOGL   2,240.71 (+3.94%)
AMZN   2,282.03 (+2.72%)
TSLA   757.43 (+7.02%)
NVDA   188.12 (+5.38%)
BABA   93.23 (-1.32%)
NIO   16.47 (+2.74%)
AMD   102.11 (+3.40%)
CGC   4.85 (-12.61%)
MU   73.30 (+3.82%)
T   21.25 (-0.33%)
GE   78.40 (+1.80%)
F   13.57 (+3.43%)
DIS   109.32 (+3.51%)
AMC   14.39 (+17.66%)
PFE   53.66 (-0.61%)
PYPL   85.13 (+5.86%)
NFLX   194.45 (+1.59%)
S&P 500   4,148.93 (+2.24%)
DOW   33,137.72 (+1.53%)
QQQ   308.13 (+2.94%)
AAPL   149.10 (+3.70%)
MSFT   271.66 (+2.17%)
FB   194.76 (+1.63%)
GOOGL   2,240.71 (+3.94%)
AMZN   2,282.03 (+2.72%)
TSLA   757.43 (+7.02%)
NVDA   188.12 (+5.38%)
BABA   93.23 (-1.32%)
NIO   16.47 (+2.74%)
AMD   102.11 (+3.40%)
CGC   4.85 (-12.61%)
MU   73.30 (+3.82%)
T   21.25 (-0.33%)
GE   78.40 (+1.80%)
F   13.57 (+3.43%)
DIS   109.32 (+3.51%)
AMC   14.39 (+17.66%)
PFE   53.66 (-0.61%)
PYPL   85.13 (+5.86%)
NFLX   194.45 (+1.59%)
S&P 500   4,148.93 (+2.24%)
DOW   33,137.72 (+1.53%)
QQQ   308.13 (+2.94%)
AAPL   149.10 (+3.70%)
MSFT   271.66 (+2.17%)
FB   194.76 (+1.63%)
GOOGL   2,240.71 (+3.94%)
AMZN   2,282.03 (+2.72%)
TSLA   757.43 (+7.02%)
NVDA   188.12 (+5.38%)
BABA   93.23 (-1.32%)
NIO   16.47 (+2.74%)
AMD   102.11 (+3.40%)
CGC   4.85 (-12.61%)
MU   73.30 (+3.82%)
T   21.25 (-0.33%)
GE   78.40 (+1.80%)
F   13.57 (+3.43%)
DIS   109.32 (+3.51%)
AMC   14.39 (+17.66%)
PFE   53.66 (-0.61%)
PYPL   85.13 (+5.86%)
NFLX   194.45 (+1.59%)
LON:BD15

Tate & Lyle (BD15) Share Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
107
112
52-Week Range
N/A
Volume
19,290 shs
Average Volume
11,015 shs
Market Capitalization
£492.44 million
P/E Ratio
1.95
Dividend Yield
5.80%
Beta
N/A

Receive BD15 News and Ratings via Email

Sign-up to receive the latest news and ratings for Tate & Lyle and its competitors with MarketBeat's FREE daily newsletter.

Tate & Lyle logo

About Tate & Lyle

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,441
Year Founded
N/A

Sales & Book Value

Annual Sales
£2.87 billion
Book Value
GBX 377.90 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£492.44 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.79 out of 5 stars

Analyst Opinion: 2.0Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -













Tate & Lyle (LON:BD15) Frequently Asked Questions

Is Tate & Lyle a good dividend stock?

Tate & Lyle pays an annual dividend of GBX 7 per share and currently has a dividend yield of 5.80%. BD15 has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Tate & Lyle is 12.73%. This payout ratio is at a healthy, sustainable level, below 75%.

What price target have analysts set for BD15?

0 brokerages have issued 12 month price targets for Tate & Lyle's shares. Their forecasts range from GBX 935 to GBX 935. On average, they expect Tate & Lyle's stock price to reach GBX 935 in the next twelve months.
View analysts' price targets for Tate & Lyle
or view top-rated stocks among Wall Street analysts.

Who are Tate & Lyle's key executives?
Tate & Lyle's management team includes the following people:
  • Mr. Nick Hampton M.A., MA (Hons), CEO & Exec. Director (Age 55, Pay $1.71M)
  • Ms. Melissa Law, Pres of Global Operations (Age 48)
  • Mr. Christopher Marsh, VP of Investor Relations
  • Ms. Lindsay Beardsell, Exec. VP & Gen. Counsel
  • Esyllt Dafydd, Global Corp. PR Mang.
  • Ms. Laura Kate Hagan, Chief Human Resource Officer (Age 48)
  • Mr. Rowan Adams, Exec. VP of Corp. Affairs
  • Mr. Andrew Taylor, Pres of Asia, Middle East, Africa & Latin America
  • Ms. Susanna Palatucci, Global Head of Health & Wellness, Innovation & Commercial Devel.
  • Mr. Tim Meinhold, Sr. VP of Global Operations & Chief Procurement Officer
What other stocks do shareholders of Tate & Lyle own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tate & Lyle investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), NIC (EGOV), Aegean Marine Petroleum Network (ANW), Continental Resources (CLR), AutoZone (AZO) and Ciner Resources (CINR).

What is Tate & Lyle's stock symbol?

Tate & Lyle trades on the London Stock Exchange (LON) under the ticker symbol "BD15."

How do I buy shares of Tate & Lyle?

Shares of BD15 and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does Tate & Lyle make?

Tate & Lyle has a market capitalization of £0.00 and generates £2.87 billion in revenue each year.

How many employees does Tate & Lyle have?

Tate & Lyle employs 4,441 workers across the globe.

What is Tate & Lyle's official website?

The official website for Tate & Lyle is www.tateandlyle.com.

How can I contact Tate & Lyle?

Tate & Lyle's mailing address is 1 Kingsway, LONDON, WC2B 6AT, United Kingdom. The company can be reached via phone at +44-20-72572100.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.